Members from EVERSANA’s Medical Affairs (MA) team conducted a comprehensive survey to understand the needs of MA professionals regarding literature surveillance, reviews and alerts. They presented their findings at the DIA Medical Affairs and Scientific Communications Forum in March 2025.
Their survey was distributed to MA professionals via LinkedIn and covered various topics related to literature alerts, medical content development and publication support. The findings highlight the importance of literature surveillance in tracking knowledge gaps, gaining competitive intelligence and supporting publication planning, medical training and value proposition development.
Key findings from the survey revealed literature surveillance is essential for strategic MA tactics. However, there is variability in how often literature surveillance is conducted and which MA teams are responsible. Additionally, AI-enabled solutions are underutilized but perceived as highly valuable in enhancing surveillance and ensuring timely insights.
To learn more about their findings, enter your information below to download detailed insights.
Author
Mary Mehrabian, PharmD, BCGP, BCMAS
Associate Director of Global Content Development and Medical Review
Mary Mehrabian is the Associate Director, Global Head of Content Development and Medical Review at EVERSANA, leading teams of medical writers, medical fact checkers, medical reviewers, and MLR coordinators in the United States, Europe,…
Mike currently serves as Senior Vice President of Medical affairs at EVERSANA. With 20+ years of healthcare and pharmaceutical industry experience in multiple leadership roles, he holds extensive experience in medical information, medical communications,…
Varun is a seasoned professional with over a decade of expertise in scientific research and medical communications, spanning both academia and the pharmaceutical industry. His extensive background includes leadership roles in scientific publications and…